IMPROVING THE APPROPRIATENESS OF INTRAVENOUS CEFTRIAXONE USE IN TUANKU AMPUAN NAJIHAH HOSPITAL

Authors

  • Marzirah Ibrahim Author
  • Kong Lai San Author
  • Dr Fauzi Azizan Abd Aziz Author
  • Clara Christian Ramanathan Author
  • Wan Ruzana Wan Jusoh Author
  • Ong Yin Sin Author

DOI:

https://doi.org/10.63719/qbulletin.v1i30.286

Keywords:

Ceftriaxone, Appropriate use, Quality improvement study

Abstract

Appropriateness of antimicrobial therapy is defined as correct decision, correct choice, and correct use of antimicrobials. Overuse and inappropriate use of intravenous ceftriaxone, a third-generation cephalosporin, will increase the resistance towards it, hence the emergence of multidrug-resistant organisms. A verification study observed that the appropriateness of intravenous ceftriaxone usage in Tuanku Ampuan Najihah Hospital (HTAN) was 21.4% in the pre-intervention phase. This study aimed to improve the appropriate use of intravenous ceftriaxone in HTAN. A quality improvement study was conducted in medical, orthopaedic, and surgical wards from 2015 to 2018. All patients who were on intravenous ceftriaxone for pneumonia treatment were recruited during the antibiotic round, except for paediatric patients. Appropriate use of intravenous ceftriaxone was measured using the indicator of the percentage of appropriate intravenous ceftriaxone cases, with a standard of more than 50% based on consensus within the AMS team members. Contributing factors of low appropriateness were no indication of antibiotic (45.46%), no de-escalation or intravenous-to-oral switch (27.27%), and inappropriate choice or duration of antibiotic (27.27%). Three intervention cycles were conducted via Antimicrobial Stewardship Programme (AMS), with each cycle lasted for at least six months. Strategies implemented were the addition of intravenous ceftriaxone into the existing Antibiotic Request Form and fortnightly antibiotic rounds to assess the prescribing of intravenous ceftriaxone, renewal of Antibiotic Request Form to be more user friendly to aid the monitoring and feedback part, continuous teaching sessions, and dialogue with pharmacy staff and nurses to ensure strict adherence to new standard operating procedures. Appropriateness of intravenous ceftriaxone use was increased from 21.4% (verification study) to 54.55% (reevaluation). The ABNA was reduced to –4.55 and ceftriaxone consumption was reduced from 90.67 DDD/1000 patient-days (January–June 2015) to 23.78 DDD/1000 patient-days (January–December 2018). Overall, multidisciplinary collaboration via AMS has successfully improved the appropriateness of intravenous ceftriaxone use in HTAN.

Author Biographies

  • Marzirah Ibrahim

    Pharmacy Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

  • Kong Lai San

    Pharmacy Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

  • Dr Fauzi Azizan Abd Aziz

    Medical Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

  • Clara Christian Ramanathan

    Pharmacy Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

  • Wan Ruzana Wan Jusoh

    Pharmacy Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

  • Ong Yin Sin

    Pharmacy Department, Tuanku Ampuan Najihah Hospital, Negeri Sembilan State Health Department, Ministry of Health Malaysia

References

1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–18.

2. Roberts RR, Hota B, Ahmad I, Scott II RD, Foster SD, Abbasi F, et al. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship. Clin Infect Dis. 2009;49(8):1175–84.

3. Ministry of Health Malaysia. National Antibiotic Guideline. 2008.

4. Ministry of Health Malaysia. National Antibiotic Guideline. 2014.

5. Veličković – Radovanović, R., Stefanović, N., Damnjanović, I., Kocić, B., Antić, S., Dinić, M., Petrović, J., Mitić, R. and Catić – Djordjević, A. (2015), Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital. J Clin Pharm Ther, 40: 426 430.

6. Durham SH, Wingler MJ, Eiland LS. Appropriate Use of Ceftriaxone in the Emergency Department of a Veteran’s Health Care System. J Pharm Technol. 2017;33(6):215–8.

7. Soman N, John SM, Panda BK, Banerjee JK. A study on prescribing pattern of cephalosporins utilization and its compliance towards the hospital antibiotic policy in surgery ward of a tertiary care teaching hospital in India. Int Surg J. 2019;6(10):3614–21.

8. Lee H, Jung D, Yeom JS, Son JS, Jung SI, Kim YS, et al. Evaluation of ceftriaxone utilization at multicenter study. Korean J Intern Med. 2009;24(4):374–80.

9. Berhe YH, Amaha ND, Ghebrenegus AS. Evaluation of ceftriaxone use in the medical ward of Halibet National Referral and teaching hospital in 2017 in Asmara, Eritrea: A cross sectional retrospective study. BMC Infect Dis. 2019;19:1–7.

10. Ali SR, Ahmed S, Lohana H. Trends of empiric antibiotic usage in a secondary care hospital, Karachi, Pakistan. Int J Pediatr. 2013;2013:832857.

11. Ayele AA, Gebresillassie BM, Erku DA, Gebreyohannes EA, Demssie DG, Mersha AG, et al. Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia. Pharmacol Res Perspect. 2018;6(1):1–7.

12. Sewagegn N, Ayichew GM, Miskir A, Degarege A, Mohammed O, Andualem T. International Journal of Pharma Sciences and Scientific Research Evaluation of Ceftriaxone Use for Hospitalized Patients in Ethiopia: The Case of a Referral Hospital. Int J Pharma Sci Sci Res. 2017;3(2):26–31.

13. Anonymous. Appropriate use of cephalosporins. Best Pract J. 2011;(41):22–8.

14. Ministry of Health. National Surveillance on Antibiotic Utilisation, Pharmacy Service Program. Unpublished reports.

15. Pharmaceutical Services Division. Protocol on Antimicrobial Stewardship Program in Healthcare Facilities. 2014;1–57.

16. Willemsen, I., Groenhuijzen, A., Bogaers, D., Stuurman, A., Van Keulen, P. & Kluytmans, J. 2007. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrobial Agents and Chemotherapy 51(3): 864–867.

17. Muller A, Lopez-Lozano JM, Bertrand X, Talon D. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J Antimicrob Chemother. 2004;54(1):173–7.

18. Afriyie DK, Amponsah SK, Dogbey J, Agyekum K, Kesse S, Truter I, et al. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hosp Pract [Internet]. 2017;45(4):143–9. Available from: https://doi.org/10.1080/21548331.2017.1348139

19. Sánchez, M. E., Gómez, J., Gómez Vargas, J., Baños, V., Ruiz Gómez, J., Muñoz, L., Simarro, E., Soto, M. C., Canteras, M., & Valdés, M. Prospective and Comparative Study Between Cefuroxime, Ceftriaxone and Amoxicillin-clavulanic Acid in the Treatment of Community-acquired Pneumonia. Rev Esp Quimioter. 1998;11(2):132-8. PubMed PMID: 9795298.

20. Xaba SN, Greeff O, Becker P. Determinants, outcomes and costs of ceftriaxone v.amoxicillin-clavulanate in the treatment of community acquired pneumonia at Witbank Hospital. S Afr Med J. 2014;104(3):187-191. doi:10.7196/samj.7243

21. Patterson, J.E., Hardin, T.C., Kelly C.A., Garcia, R.C. & Jorgensen, J.H. 2000. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infection Control & Hospital Epidemiology 21(7): 455-458.

22. Naveed S, Sarwar G, Hassan R, Khan S, Afzal S, Naz S, et al. Irrational use of cephalosporin and quinolones in public and private sectors Hospitals of Karachi. J App Pharm. 2014;6(3):252–60.

23. Baadani AM, Baig K, Alfahad WA, Aldalbahi S, Omrani AS. Physicians’ knowledge, perceptions, and attitudes toward antimicrobial prescribing in Riyadh, Saudi Arabia. 2015;36(5):613–9.

24. Calbo E, Luis Á-R, Francisco G, Juan P. A review of the factors influencing antimicrobial prescribing. Enferm Infecc Microbiol Clin [Internet]. 2013;31(4):12–5.25. Charani E, Sevdalis N, Kyratsis Y, Drumright L, Shah N, Holmes A. Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette.” Clin Infect Dis. 2013;57(2):188–96.

26. Charani E, Castro-sánchez E, Holmes A. The Role of Behavior Change in Antimicrobial Stewardship. Infect Dis Clin NA [Internet]. 2014;28(2):169–75.

27. Livorsi D, Comer A, Matthias M, And EP, Bair M. Factors influencing antibiotic-prescribing decisions among inpatient physicians: A qualitative investigation. Infect Control Hosp Epidemiol. 2015;36(9):1065–72.

28. Skrlin J, Bacic Vrca V, Marusic S, Ciric-Crncec M, Mayer L. Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption. J Chemother. 2011;23(6):341–4.

29. Lee, S-O, Lee, E.S., Park S.Y., Kim, S-Y., Seo, Y-H & Cho, Y.K. 2004. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumonia. Infection Control & Hospital Epidemiology 25(10):832 837.

30. Ayele, A. A., Gebresillassie, B. M., Erku, D. A., Gebreyohannes, E. A., Demssie, D. G., Mersha, A. G. & Tegegn, H. G. 2018. Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia. Pharmacology Research and Perspectives 6(1): 1–7. doi:10.1002/prp2.383

31. Sonda, T. B., Horumpende, P. G., Kumburu, H. H., van Zwetselaar, M., Mshana, S. E., Alifrangis, M., Lund, O., et al. 2019. Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme. PLoS ONE 14(8): 1–11. doi:10.1371/journal.pone.0220261

32. Crayton E, Richardson M, Fuller C, Smith C, Liu S, Forbes G, et al. Interventions to improve appropriate antibiotic prescribing in long-term care facilities: A systematic review. BMC Geriatr. 2020;20(237).

33. Davey P, Scott CL, Brown E, Charani E, Michie S, Ramsay CR, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients (updated protocol). Cochrane Database Syst Rev. 2017;(2).

34. Tiri B, Bruzzone P, Priante G, Sensi E, Costantini M, Vernelli C, et al. Impact of Antimicrobial Stewardship Interventions on Appropriateness of Surgical Antibiotic Prophylaxis: How to Improve. Antibiotics. 2020;9(168).

35. World Health Organization. More about DDDs. Accessed on 17 August 2020.

https://www.who.int/medicines/regulation/medicines-safety/toolkit_ddd_more/en/

Downloads

Published

31-10-2021

Issue

Section

Articles

How to Cite

1.
IMPROVING THE APPROPRIATENESS OF INTRAVENOUS CEFTRIAXONE USE IN TUANKU AMPUAN NAJIHAH HOSPITAL. Q Bulletin [Internet]. 2021 Oct. 31 [cited 2026 Nov. 23];1(30). Available from: https://journal.nih.gov.my/index.php/qbulletin/article/view/286

Similar Articles

31-40 of 40

You may also start an advanced similarity search for this article.